Stereotactic Surgery Devices Market Report
Stereotactic Surgery Devices Market by Product (Gamma Knife, LINAC, PBRT, and Cyber Knife), Application (Liver, Breast, Prostate, Lung, Colon, and Others), and Region (North America, Europe, Asia-Pacific, and LAMEA): Opportunity Analysis and Industry Forecast, 2023-2032
Stereotactic Surgery Devices Overview
Stereotactic surgery devices are medical devicesused in the specialized technique of stereotactic surgery. This minimally invasive procedure involves targeting specific areas within the brain or other body parts for diagnostic or therapeutic purposes. Stereotactic surgery devices have three main components: a frame or frameless system, imaging technology, and a navigation system. The structure or frameless system establishes a fixed reference point in space, while imaging techniques like MRI, CT, or PET create detailed 3D images of the target area. The navigation system integrates the imaging data and guides the surgeon’s instruments in real time, ensuring accuracy and safety. These devices are commonly used in neurosurgical procedures such as deep brain stimulation, biopsies, tumor resections, and other therapeutic interventions.
Global Stereotactic Surgery Devices Market Analysis
The global stereotactic surgery devices market size was $25.36 billion in 2022 and is predicted to grow at a CAGR of 5.4%, by generating a revenue of $41.61 billion by 2032.
COVID-19 Impact on Global Stereotactic Surgery Devices Market
The COVID-19 pandemic has impacted the stereotactic surgery devices market in several ways. Initially, there were short-term disruptions as healthcare systems focused on managing the overwhelming number of COVID-19 cases, leading to the postponement or cancellation of non-essential surgeries, including stereotactic procedures. As the situation improved and healthcare systems adapted, there was a gradual recovery in elective surgeries, including stereotactic procedures. However, the pace of recovery varied across regions. Additionally, there was an increased emphasis on safety measures, such as infection prevention and control protocols, which affected the workflow and processes related to stereotactic surgery and associated devices. The pandemic also highlighted the importance of technological advancements in healthcare, which may impact the development and adoption of new stereotactic surgery devices. Furthermore, global supply chain disruptions have affected the manufacturing, distribution, and availability of these devices.
Increasing Prevalence of Neurological Disorders to Drive the Market Growth
The growth of the stereotactic surgery devices market is fueled by various factors. One significant factor is the increasing prevalence of neurological disorders like Parkinson's, epilepsy, brain tumor, and essential tremors. As these conditions become more widespread, the demand for stereotactic surgery devices rises accordingly. Additionally, continuous technological advancements in these devices have significantly improved their precision, safety, and efficacy. Innovations like image-guided systems, robotic-assisted systems, and real-time imaging have enhanced the accuracy of targeting specific areas within the brain, attracting healthcare providers and supporting market growth. Furthermore, the growing demand for minimally invasive procedures has contributed to adopting stereotactic surgery devices, as they offer reduced scarring, shorter hospital stays, quicker recovery times, and lower risks of complications. The aging global population is another influential factor, as age-related neurological disorders become more prevalent, leading to an increased patient pool for stereotactic surgery devices.
To know more about global stereotactic surgery devices market drivers, get in touch with our analysts here.
High Cost to Restrain the Market Growth
Several factors can restrain the growth of the stereotactic surgery devices market. One significant factor is the high cost of these devices, making them inaccessible to many healthcare facilities and individuals, particularly in resource-constrained regions. Additionally, limited awareness and the need for specialized training can hinder adoption as healthcare professionals may need proper knowledge and expertise to incorporate these devices. Concerns regarding stereotactic surgery’s safety and potential complications can also restrict its widespread use. Moreover, navigating the complex regulatory landscape and obtaining necessary approvals can take time and effort, further impeding market growth.
Advancements in Technology to Drive Excellent Opportunities
The stereotactic surgery devices market presents several growth opportunities. Technological advancements, such as improved imaging strategies and robotic-assisted systems, can upgrade the precision and safety of these devices. With the rising predominance of neurological disorders like Parkinson's disease and brain tumor, stereotactic surgery devices can play a vital role in their treatment. Moreover, the request for minimally invasive procedures is increasing, and stereotactic surgery devices offer the advantage of reduced hospital stays and faster recovery times. Investing in healthcare infrastructure, including specialized neurological centers, creates a favorable environment for adopting advanced medical technologies like stereotactic surgery devices. Moreover, growing awareness and training programs for healthcare professionals can drive the adoption of these devices. As the applications of stereotactic surgery devices expand beyond neurosurgical procedures, such as in stereotactic radiosurgery for cancer treatment, new opportunities are emerging.
Global Stereotactic Surgery Devices Market Share, by Product, 2022
The PBRT sub-segment accounted for the highest market share in 2022. Proton beam radiation therapy (PBRT) can impact the stereotactic surgery devices market in several ways. PBRT is an advanced radiation therapy that uses precise proton beams to target tumors while minimizing damage to surrounding healthy tissues. Integration of stereotactic surgery devices with PBRT can enhance treatment precision and accuracy. This could lead to an increased demand for advanced stereotactic surgery devices that integrate with PBRT systems, including specialized treatment planning and delivery systems. Technological advancements may arise as PBRT techniques improve the compatibility of stereotactic surgery devices with PBRT systems. The growing recognition of PBRT as an effective treatment option may expand the market, encouraging competition and innovation among medical device manufacturers.
Global Stereotactic Surgery Devices Market Share, by Application, 2022
The breast sub-segment accounted for the highest market share in 2022. The dominance of breast-related procedures in the stereotactic surgery devices market can be attributed to several factors. Breast conditions, such as breast cancer and benign breast lesions are prevalent, particularly among women, creating a significant demand for diagnostic and treatment procedures. In addition, advancements in breast imaging techniques, such as mammography, have integrated with stereotactic surgery devices, enabling precise localization and targeting of abnormalities in breast tissue. This integration has led to accurate diagnosis and minimally invasive treatment options, further fueling the demand for these devices. Additionally, the capacity of stereotactic surgery devices to facilitate minimally intrusive strategies, including biopsies and lumpectomies, has contributed to their popularity. These methods offer advantages, such as littler incisions, reduced scarring, shorter recovery times, and fewer complications. Furthermore, the focus on early detection and intervention in breast conditions, especially breast cancer, has driven the adoption of stereotactic surgery devices. These devices play a crucial role in early diagnosis through procedures like stereotactic-guided biopsies, improving patient outcomes and survival rates.
Global Stereotactic Surgery Devices Market Share, by Region, 2022
The North America stereotactic surgery devices market generated the highest revenue in 2022. The dominance of the region in the stereotaxic surgery market is attributed to advanced medical infrastructure, technological advancements, skilled medical professionals, favorable regulatory environment, robust R&D ecosystem, high medical spending, and increasing prevalence of neurological disorders. In addition, the well-established medical infrastructure in the North America region, including world-class hospitals and research centers, has encouraged advancing and adopting innovative medical technologies. The companies located in the region have pioneered technological advances in stereotaxic surgery, presenting state-of-the-art technologies such as image-guided systems and robotic platforms. The availability of skilled healthcare professionals trained in these devices has further propelled the region's dominance. Moreover, the high healthcare spending in North America region supports the widespread adoption of advanced medical technologies.
Competitive Scenario in the Global Stereotactic Surgery Devices Market
Investment and partnerships are common strategies followed by major market players. One of the leading market players in the industry is Elekta AB. For instance, in June 2021, Elekta extended its partnership with Philips to streamline the path from cancer diagnosis to survivorship for better outcomes. Key players are also trying to retain their strong position in the market by launching technologically advanced products.
Some of the leading stereotactic surgery devices market players are Koninklijke Philips N.V., Hitachi Medical Systems, Huiheng Group, Siemens Ag, Elekta AB, Varian Medical Systems, IBA, and Accuray Incorporated.
Historical Market Estimations
Base Year for Market Estimation
Forecast Timeline for Market Projection
North America, Europe, Asia-Pacific, and LAMEA
Segmentation by Product
Segmentation by Application
Key Companies Profiled
Q1. What is the size of the global stereotactic surgery devices market?
A. The size of the global stereotactic surgery devices market was over $25.36 billion in 2022 and is projected to reach $41.61 billion by 2032.
Q2. Which are the major companies in the stereotactic surgery devices market?
A. IBA and Accuray Incorporated are some of the key players in the global stereotactic surgery devices market.
Q3. Which region, among others, possesses greater investment opportunities in the near future?
A. The North America region possesses great investment opportunities for investors to witness the most promising growth in the future.
Q4. What are the strategies opted by the leading players in this market?
A. Partnerships and investment are the two key strategies opted by the operating companies in this market.
Q5. Which companies are investing more on R&D practices?
A. Huiheng Group, Siemens Ag, Elekta AB, and Varian Medical Systems are the companies investing more on R&D activities for developing new products and technologies.